Drug WatchRisk of Rare, Serious Genital Infection from some Diabetes DrugsAschenbrenner, Diane S. MS, RNAuthor Information Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: email@example.com. AJN, American Journal of Nursing: December 2018 - Volume 118 - Issue 12 - p 23 doi: 10.1097/01.NAJ.0000549687.43759.a5 Buy Metrics Abstract Sodium–glucose cotransporter-2 (SGLT2) inhibitors, used to treat type 2 diabetes, now carry a warning regarding the risk of necrotizing fasciitis of the perineum. NPs should assess for this rare genital infection if a patient taking an SGLT2 inhibitor presents with redness, swelling, and pain in the genitals or in the area from the genitals to the rectum, and has a fever above 100.4°F or general malaise. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.